Propharma Group Mis Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Propharma Group Mis Limited - overview
Established
2001
Location
Richmond, -, UK
Primary Industry
Information Services
About
Propharma Group Mis Limited is a consulting firm specializing in regulatory sciences, clinical research, compliance, pharmacovigilance, and medical information services tailored for the pharmaceutical and biotechnology sectors. Founded in 2001 by Julien Lachance, Propharma Group Mis Limited provides consulting services that assist pharmaceutical, biotechnology, and medical device organizations throughout the product lifecycle. The company is headquartered in [specific location not provided]. ProPharma specializes in providing a comprehensive suite of consulting services aimed at supporting pharmaceutical, biotechnology, and medical device organizations across the entire product lifecycle.
Their core offerings include regulatory sciences, clinical research, compliance, pharmacovigilance, and medical information services. These services are designed to navigate the complexities of drug development, ensuring that clients can bring innovative therapies to market efficiently and safely. ProPharma serves a global client base, which includes biotech and pharmaceutical companies, as well as medical device manufacturers, primarily across North America, Europe, and Asia. The end users of ProPharma's services are healthcare providers, regulatory bodies, and ultimately, patients who benefit from the advanced therapies that ProPharma helps to develop and commercialize.
ProPharma generates revenue through a structured model that includes service-based agreements and partnerships with clients in the life sciences sector. The company typically engages in B2B transactions, delivering tailored consulting services that align with the specific needs of each client. This may involve establishing long-term partnerships for ongoing regulatory and compliance support or project-based engagements for clinical development and pharmacovigilance services. ProPharma's pricing structure is often based on the scope and complexity of the services provided, allowing for flexible arrangements that cater to the unique demands of each client.
While specific pricing plans are not publicly disclosed, the firm's established reputation and extensive expertise position it as a trusted partner in facilitating successful product launches and market entry strategies for its clients.
Primary Industry
Information Services
Sub Industries
Information Services
Website
http://www.propharmagroup.com
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.